Dr. Jason Eugene Lemoine, MD

Dr. Lemoine practices at Rinehart Surgery Center in Lake Mary, Florida.

Dr. Lemoine's NPI, 1154328375, was assigned on July 1, 2005. Dr. Lemoine graduated from USF Health Morsani College of Medicine in 1999. Dr. Lemoine holds Florida license ME89927.

Dr. Lemoine's primary practice is Rinehart Surgery Center, at 392 Rinehart Rd Ste 1090, Lake Mary, FL 32746. The practice phone is (321) 363-9400.

Dr. Lemoine's primary practice is Rinehart Surgery Center in Lake Mary, Florida. Dr. Lemoine is also affiliated with AdventHealth Orlando. The medical group on file is Orlando Health Medical Group. Dmand AI also links Dr. Lemoine to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lemoine practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Lemoine's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Lemoine is board certified in urology by the American Board of Urology. Dr. Lemoine is licensed in Florida.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and kidney stones among the conditions Dr. Lemoine treats.

CMS data shows 3,023 Medicare services from Dr. Lemoine across 15 procedure codes in 2024, for 835 Medicare patients. Medicare paid $142,541 for them. Every service was in an office.

CMS counts 835 Medicare patients who saw Dr. Lemoine in 2024. The largest group is 65 to 74, with 371 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.18, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lemoine's median patient age at 69, with 18% women.

In 2024, Dr. Lemoine wrote 2,462 Medicare Part D claims for 717 patients. 90% of them were for generic drugs. CMS names the drug for 2,365 of them, across 35 drugs with 11 or more claims each, at $331,700 in total drug cost. In 2023, CMS named 1,951 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Lemoine for performance year 2024, reported as part of a group. Dr. Lemoine accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Lemoine. Dr. Lemoine's most frequent co-author is Jorge L. Lockhart, MD.

CMS Open Payments shows 406 general payments to Dr. Lemoine from 58 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 86% of the total. Myriad Genetic Laboratories, Inc. paid the most, $1,499.

Dmand AI lists 1 award for Dr. Lemoine, most recently CMS Stage 1 2012 in 2011.

Dr. Lemoine graduated from USF Health Morsani College of Medicine in 1999.

Dr. Lemoine is in network with 17 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.